Erasca, Inc.

ERAS chart

Erasca, Inc. news

• Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ:

  GlobeNewswire · Nov 9, 8:04 AM EST

• Erasca, Inc. (ERAS) Seasonal Returns Chart - Yahoo Finance

  Yahoo! Finance Canada · Nov 6, 4:00 PM EST

• Erasca (ERAS) Could Be 45% Undervalued On New Cancer Trial Progress

  Simply Wall St · Nov 6, 6:39 AM EST

• Erasca COO departure sparks securities fraud in...

  Pluang · Nov 5, 8:06 PM EST

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

  PR Newswire · Nov 5, 7:42 PM EST

• Tango and Erasca’s Phase I/II trial of ERAS-0015 combo opens for enrolment

  Clinical Trials Arena · Nov 5, 7:34 AM EST

• What Erasca (ERAS)'s Cancer Drug Trial Start Means For Shareholders

  Simply Wall St · Nov 5, 4:31 AM EST

• What Could the Tango Therapeutics (NASDAQ:TNGX) and Erasca Phase 1/2 Study Mean for Pancreatic Cancer Treatment?

  Kalkine · Nov 4, 8:40 PM EST

• Important Notice to Long-Term Shareholders of Erasca, Inc.

  GlobeNewswire · Nov 4, 11:11 AM EST

• Tango and Erasca launch Phase 1/2 trial combini...

  Pluang · Nov 4, 8:45 AM EST

• Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

  Yahoo Finance · Nov 4, 8:30 AM EST

• Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5

  GlobeNewswire · Nov 4, 8:30 AM EST

Erasca, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-16
• 8-K8-K2026-08-24
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-08-10
• 8-K8-K2026-07-14
• 8-K8-K2026-07-13
• 8-K8-K2026-07-01
• 10-Q10-Q2026-05-11
• 8-K8-K2026-05-11
• DEF 14ADEF 14A2026-04-28
• 8-K8-K2026-04-27

About Erasca, Inc.

Ticker

ERAS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1761918

Frequently asked questions